Molecular basis of cytokine receptor activation - PubMed (original) (raw)
Review
doi: 10.1002/iub.350.
Timothy R Hercus, Paul Ekert, Dene R Littler, Mark Guthridge, Daniel Thomas, Hayley S Ramshaw, Frank Stomski, Michelle Perugini, Richard D'Andrea, Michele Grimbaldeston, Michael W Parker
Affiliations
- PMID: 20540154
- DOI: 10.1002/iub.350
Free article
Review
Molecular basis of cytokine receptor activation
Angel F Lopez et al. IUBMB Life. 2010 Jul.
Free article
Abstract
Cytokines are secreted soluble peptides that precisely regulate multiple cellular functions. Amongst these the GM-CSF/IL-3/IL-5 family of cytokines controls whether hematopoietic cells will survive or apoptose, proliferate, differentiate, migrate, or perform effector functions such as phagocytosis or reactive oxygen species release. Their potent and pleiotropic activities are mediated through binding to high affinity membrane receptors at surprisingly low numbers per cell. Receptor binding triggers a cascade of intracellular signaling events, including reversible phosphorylation of receptor subunits and associated signaling molecules, leading to multiple biological responses, with the prevention of apoptosis or "cell survival" being a key cellular function that underpins all others. Many chronic inflammatory diseases and a number of haematological malignancies are driven by deregulated GM-CSF, IL-3, or IL-5 cytokine receptor signaling, highlighting their importance in disease. A major step in understanding how these cytokine receptors function is to elucidate their three dimensional structure and to relate this to the many signaling pathways emanating from their receptors. We have recently solved the structure of the human GM-CSF receptor complexed to GM-CSF which revealed distinct forms of receptor assembly: a hexamer that comprises two molecules each of GM-CSF, GM-CSF receptor alpha chain and GM-CSF receptor beta chain; and an unexpected dodecamer in which two hexameric complexes associate through a novel site 4. This latter form is necessary to bring JAK2 molecules sufficiently close together to enable full receptor activation. In this review we focus on the most recent insights in cytokine receptor signaling, and in receptor assembly. The stage is now set to link distinct forms of cytokine receptor assembled structures to specific forms of cytokine receptor signaling and function. Armed with this knowledge it may be possible to map distinct cytokine receptor signaling pathways from the cell surface to the cell nucleus which may themselves become new therapeutic targets.
(c) 2010 IUBMB IUBMB Life.
Similar articles
- Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A, Arai K. Yoshimura A, et al. Oncologist. 1996;1(5):337-339. Oncologist. 1996. PMID: 10388012 - The Ig-like domain of human GM-CSF receptor alpha plays a critical role in cytokine binding and receptor activation.
Mirza S, Walker A, Chen J, Murphy JM, Young IG. Mirza S, et al. Biochem J. 2010 Feb 24;426(3):307-17. doi: 10.1042/BJ20091745. Biochem J. 2010. PMID: 20078425 - Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors.
Guthridge MA, Stomski FC, Thomas D, Woodcock JM, Bagley CJ, Berndt MC, Lopez AF. Guthridge MA, et al. Stem Cells. 1998;16(5):301-13. doi: 10.1002/stem.160301. Stem Cells. 1998. PMID: 9766809 Review. - The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.
Broughton SE, Dhagat U, Hercus TR, Nero TL, Grimbaldeston MA, Bonder CS, Lopez AF, Parker MW. Broughton SE, et al. Immunol Rev. 2012 Nov;250(1):277-302. doi: 10.1111/j.1600-065X.2012.01164.x. Immunol Rev. 2012. PMID: 23046136 Review.
Cited by
- GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia.
Padron E, Painter JS, Kunigal S, Mailloux AW, McGraw K, McDaniel JM, Kim E, Bebbington C, Baer M, Yarranton G, Lancet J, Komrokji RS, Abdel-Wahab O, List AF, Epling-Burnette PK. Padron E, et al. Blood. 2013 Jun 20;121(25):5068-77. doi: 10.1182/blood-2012-10-460170. Epub 2013 Apr 30. Blood. 2013. PMID: 23632888 Free PMC article. - Up-regulation of Kv1.3 channels by janus kinase 2.
Hosseinzadeh Z, Warsi J, Elvira B, Almilaji A, Shumilina E, Lang F. Hosseinzadeh Z, et al. J Membr Biol. 2015 Apr;248(2):309-17. doi: 10.1007/s00232-015-9772-2. Epub 2015 Feb 3. J Membr Biol. 2015. PMID: 25644777 - The receptor that tames the innate immune response.
Brines M, Cerami A. Brines M, et al. Mol Med. 2012 May 9;18(1):486-96. doi: 10.2119/molmed.2011.00414. Mol Med. 2012. PMID: 22183892 Free PMC article. Review. - Downregulation of KCNQ4 by Janus kinase 2.
Hosseinzadeh Z, Sopjani M, Pakladok T, Bhavsar SK, Lang F. Hosseinzadeh Z, et al. J Membr Biol. 2013 Apr;246(4):335-41. doi: 10.1007/s00232-013-9537-8. Epub 2013 Mar 30. J Membr Biol. 2013. PMID: 23543186 - Unexpected mechanisms of action for a cytokine receptor-blocking antibody.
Hercus TR, Broughton SE, Hardy MP, Nero TL, Wilson NJ, Parker MW, Lopez AF. Hercus TR, et al. Mol Cell Oncol. 2014 Dec 31;1(4):e969129. doi: 10.4161/23288604.2014.969129. eCollection 2014 Oct-Dec. Mol Cell Oncol. 2014. PMID: 27308368 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous